188 results
8-K
EX-99.1
ENZ
Enzo Biochem, Inc.
13 Mar 24
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
4:31pm
as its primary indicator of performance, and refers to Adjusted EBITDA to further exclude items of a non-recurring nature. It is reasonable to expect
DEFR14A
ENZ
Enzo Biochem, Inc.
21 Dec 23
Revised proxy
4:48pm
and is advisory in nature. Abstentions and broker non-votes will not be counted as “votes cast” and will have no effect on the outcome of the vote with respect … shown.
Title of Class
Name and Address of Beneficial Owner(1)
Amount and
Nature of
Beneficial
Ownership(1)
Percent of
Class(2)
Named Executive
8-K/A
EX-99.1
2woy9qdwws0royjq8l
28 Jul 23
Financial Statements and Exhibits
5:19pm
424B3
is5783n
18 Jul 23
Prospectus supplement
9:42pm
424B3
jj7xhe5p3a
21 Jun 23
Prospectus supplement
8:44pm
8-K
EX-99.1
i7beoysx7
16 Jun 23
Other Events
4:01pm
D
j9yi1
2 Jun 23
$7.00 mm in options, sold $7.00 mm, 3 investors
5:41pm
8-K
EX-10.3
npr91v pnbgyp0lr
22 May 23
Entry into a Material Definitive Agreement
6:32am
8-K
EX-10.4
eigypdd
22 May 23
Entry into a Material Definitive Agreement
6:32am